Alaunos Therapeutics Inc (TCRT)
2.39
+0.07
(+3.02%)
USD |
NASDAQ |
Nov 22, 16:00
2.355
-0.04
(-1.46%)
After-Hours: 20:00
Alaunos Therapeutics Max Drawdown (5Y): 99.76% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.76% |
| September 30, 2024 | 99.74% |
| August 31, 2024 | 99.74% |
| July 31, 2024 | 99.64% |
| June 30, 2024 | 99.40% |
| May 31, 2024 | 99.36% |
| April 30, 2024 | 99.36% |
| March 31, 2024 | 99.36% |
| February 29, 2024 | 99.36% |
| January 31, 2024 | 99.36% |
| December 31, 2023 | 99.36% |
| November 30, 2023 | 99.09% |
| October 31, 2023 | 98.91% |
| September 30, 2023 | 98.24% |
| August 31, 2023 | 98.22% |
| July 31, 2023 | 94.54% |
| June 30, 2023 | 94.54% |
| May 31, 2023 | 94.54% |
| April 30, 2023 | 94.54% |
| March 31, 2023 | 94.54% |
| February 28, 2023 | 94.54% |
| January 31, 2023 | 94.54% |
| December 31, 2022 | 94.54% |
| November 30, 2022 | 94.54% |
| October 31, 2022 | 94.54% |
| Date | Value |
|---|---|
| September 30, 2022 | 94.54% |
| August 31, 2022 | 94.54% |
| July 31, 2022 | 94.54% |
| June 30, 2022 | 94.54% |
| May 31, 2022 | 94.54% |
| April 30, 2022 | 94.54% |
| March 31, 2022 | 91.68% |
| February 28, 2022 | 89.18% |
| January 31, 2022 | 89.12% |
| December 31, 2021 | 88.95% |
| November 30, 2021 | 88.95% |
| October 31, 2021 | 88.95% |
| September 30, 2021 | 88.95% |
| August 31, 2021 | 88.95% |
| July 31, 2021 | 88.95% |
| June 30, 2021 | 88.95% |
| May 31, 2021 | 88.95% |
| April 30, 2021 | 88.95% |
| March 31, 2021 | 88.95% |
| February 28, 2021 | 88.95% |
| January 31, 2021 | 88.95% |
| December 31, 2020 | 88.95% |
| November 30, 2020 | 88.95% |
| October 31, 2020 | 88.95% |
| September 30, 2020 | 88.95% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
88.95%
Minimum
Nov 2019
99.76%
Maximum
Oct 2024
93.07%
Average
94.54%
Median
Apr 2022
Max Drawdown (5Y) Benchmarks
| Microbot Medical Inc | 99.80% |
| SELLAS Life Sciences Group Inc | 100.00% |
| Galectin Therapeutics Inc | 88.76% |
| Oragenics Inc | 99.67% |
| Anavex Life Sciences Corp | 88.25% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -64.22 |
| Beta (5Y) | -0.4933 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 133.9% |
| Historical Sharpe Ratio (5Y) | -0.5274 |
| Historical Sortino (5Y) | -1.324 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 44.48% |